Search

everythinglearnresearchcommunity

for

Search:↓

Critically ill patients may experience temporary hair loss after a fever.

Hair loss can happen after a fever caused by Rickettsia conorii infection.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Most patients experience temporary hair loss after ECMO, but it usually grows back within 6 months without treatment.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

COVID-19 infection can significantly cause temporary hair loss.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

COVID-19 may trigger sudden temporary hair loss.

COVID-19 infection may cause hair loss a few months after recovery.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Weight loss can cause temporary hair loss, especially in women and older adults.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

A systematic approach is crucial for managing hair loss in women.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Systemic diseases can cause hair loss, which is often reversible with treatment.